Table 1.
Base, favorable (fav.) and unfavorable (unfav.) utility estimates and durations for each health state.
Health state | Utility estimate | Source of utility estimate |
Duration | Source of duration | ||
---|---|---|---|---|---|---|
base | fav. | unfav. | ||||
Screening attendance | 0.99 | 1 | 0.99 | 17, 30 | 1 week | Assumption |
Biopsy | 0.90 | 0.94 | 0.87 | 30 | 3 weeks | Assumption |
Diagnosis | 0.80 | 0.85 | 0.75 | based on43 | 1 month | Assumption |
Radiation therapy (RT) | 0.73 | 0.91 | 0.71 | 19 | 2 months | 19 |
Radical prostatectomy (RP) | 0.67 | 0.9 | 0.56 | 19 | 2 months | 19 |
Active surveillance | 0.97 | 1 | 0.85 | 44–46 | 7 years | 47 |
2 months – 1 year RT | 0.78 | 0.88 | 0.61 | 48 | 10 months | 18 |
2 months – 1 year RP | 0.77 | 0.91 | 0.70 | 49 | 10 months | 18 |
Post-recovery period | 0.95 | 1 | 0.93 | 18, 19 | 9 years* | Assumption |
Palliative therapy | 0.60 | 0.24 | 0.86 | 50–53 | 30 months | 54 |
Terminal illness | 0.40 | 0.24 | 0.40 | 50, 52, 53 | 6 months | 52, 53 |
The duration of the post-recovery period used for the sensitivity analysis was the residual life-time38